Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Daniel O'Day
AddedApr 2, 2024
UpdatedMay 31, 2026
Daniel O'Day

Daniel O'Day

Board Member, Genentech

CrunchbaseLinkedIn

Daniel O'Day's Career

Genentech
Genentech

South San Francisco, CA, US

Board Member· Board
Foundation Medicine
Foundation Medicine

Cambridge, MA, US

Board Member· Board
Gilead Sciences
Gilead Sciences

Foster City, CA, US

Board Member· Board
Flatiron Health
Flatiron Health

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Daniel O'Day's Career

Genentech
Genentech
Public13.5k1976South San Francisco, CA, US
Board Member· Board

Leadership at Genentech

Alexander HardyAlexander HardyCEO
Robert A. SwansonRobert A. SwansonCo-Founder
Herbert BoyerHerbert BoyerCo-Founder
Richard P. LiftonRichard P. LiftonBoard Member
Severin SchwanSeverin SchwanBoard Member
Yousuke MatsushimaYousuke MatsushimaBoard Member
Foundation Medicine
Foundation Medicine
Public$96.5M6622010Cambridge, MA, US
Board Member· Board

Leadership at Foundation Medicine

Alexis BorisyAlexis BorisyBoard Member
Michael PelliniMichael PelliniBoard Member
Evan JonesEvan JonesBoard Member
Brian AlexanderBrian AlexanderCEO
Gilead Sciences
Gilead Sciences
Public$2B17k1987Foster City, CA, US
Board Member· Board

Leadership at Gilead Sciences

Jacqueline K. BartonJacqueline K. BartonBoard Member
Kelly A. KramerKelly A. KramerBoard Member
Kevin LoftonKevin LoftonBoard Member
Daniel O’DayDaniel O’DayBoard Member
Michael L. RiordanMichael L. RiordanFounder
James M DennyJames M DennyBoard Member

Similar to Gilead Sciences

Bristol Myers SquibbBristol Myers SquibbNew York City, NY, USPharmaceuticalsest. 1887Bristol Myers SquibbNew York City, NY, US · est. 1887

Leading American pharmaceutical company specializing in research and development.

Public · $10.6B34.3k
GenentechGenentechSouth San Francisco, CA, USBiopharmaceuticalsest. 1976GenentechSouth San Francisco, CA, US · est. 1976

Genentech, Inc.: A pioneering US biotech firm, operating as an independent subsidiary of Roche.

Public13.5k
GSKGSKLondon, Greater London, GBBiotech, Pharmaceuticalsest. 2000GSKLondon, Greater London, GB · est. 2000

GSK PLC: A British multinational firm innovating in pharmaceuticals, biotech, and health products.

Public · $25.5M69.4k
Rigel PharmaceuticalsRigel PharmaceuticalsSouth San Francisco, CA, USPharmaceuticalsest. 1996Rigel PharmaceuticalsSouth San Francisco, CA, US · est. 1996

Rigel Pharmaceuticals: A US-based biotech firm innovating small-molecule drugs for rare diseases and cancer.

Public · $192.5M155
Flatiron Health
Flatiron Health
Series D$324.9M1.9k2012New York City, NY, US
Board Member· Board

Leadership at Flatiron Health

Zach WeinbergZach WeinbergCo-Founder
Krishna YeshwantKrishna YeshwantBoard Member
Carolyn StarrettCarolyn StarrettCEO
Nat TurnerNat TurnerBoard Member
Dr Andrew J Conrad PhDDr Andrew J Conrad PhDBoard Member

Daniel O'Day's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Daniel O'Day

Jeffrey LeidenJeffrey LeidenBoard Member · Vertex PharmaceuticalsJean-Jacques BienaimeJean-Jacques BienaimeBoard Member · Fox Chase Cancer CenterDave RicksDave RicksBoard Member · Eli Lilly and CompanyGeorge ScangosGeorge ScangosBoard Member · Agilent TechnologiesRichard GonzalezRichard GonzalezBoard Member · AbbVieReshma KewalramaniReshma KewalramaniBoard Member · Ginkgo Bioworks